Patents by Inventor Merve YILDIRIM

Merve YILDIRIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240066091
    Abstract: A product including plant-derived nanovesicles which induce differentiation of the stem cell sources into cartilage and bone cells is provided. The objective of the invention is to improve the rate of differentiation into cartilage and bone cells, enhance strength of the obtained tissue and to provide a non-toxic application with lower cost by means of giving plant exosomes in addition to the differentiation media to the adipose-derived stem cells.
    Type: Application
    Filed: December 27, 2021
    Publication date: February 29, 2024
    Applicant: YEDITEPE UNIVERSITESI
    Inventors: Fikrettin SAHIN, Polen KOCAK, Merve YILDIRIM
  • Patent number: 10881706
    Abstract: A product containing plant derived exosome that may be used in cancer treatment and wound healing. The product enables to provide a low-cost product, which does not cause toxic effects in human body, does not cause damage in the healthy cells during the course of the cancer treatment, does not pose any infection risk since it does not require any procedure such as radiotherapy or surgery, and the side effects occurring in chemotherapy treatment are not experienced. Wheatgrass, garlic and ginger can be used alone or in combination in the product as the plant source.
    Type: Grant
    Filed: January 31, 2018
    Date of Patent: January 5, 2021
    Assignee: YEDITEPE UNIVERSITESI
    Inventors: Fikrettin Sahin, Merve Yildirim, Polen Kocak, Burge Ulukan
  • Publication number: 20200230196
    Abstract: A product containing plant derived exosome that may be used in cancer treatment and wound healing. The product enables to provide a low-cost product, which does not cause toxic effects in human body, does not cause damage in the healthy cells during the course of the cancer treatment, does not pose any infection risk since it does not require any procedure such as radiotherapy or surgery, and the side effects occurring in chemotherapy treatment are not experienced. Wheatgrass, garlic and ginger can be used alone or in combination in the product as the plant source.
    Type: Application
    Filed: January 31, 2018
    Publication date: July 23, 2020
    Applicant: YEDITEPE UNIVERSITESI
    Inventors: Fikrettin SAHIN, Merve YILDIRIM, Polen KOCAK, Burge ULUKAN